Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Japon400
Taku Hatano9
Japon Sauf Taku Hatano" 391
Taku Hatano Sauf Japon" 0
Japon Et Taku Hatano 9
Japon Ou Taku Hatano 400
Corpus10303
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000952 Taku Hatano [Japon]Induced pluripotent stem cells can be a useful disease model for understanding the pathomechanisms of PARK2.
000B59 Maya Ando [Japon] ; Manabu Funayama ; Yuanzhe Li ; Kenichi Kashihara ; Yoshitake Murakami ; Nobutaka Ishizu ; Chizuko Toyoda ; Katsuhiko Noguchi ; Takashi Hashimoto ; Naoki Nakano ; Ryogen Sasaki ; Yasumasa Kokubo ; Shigeki Kuzuhara ; Kotaro Ogaki ; Chikara Yamashita ; Hiroyo Yoshino ; Taku Hatano ; Hiroyuki Tomiyama ; Nobutaka HattoriVPS35 mutation in Japanese patients with typical Parkinson's disease.
000C79 Taku Hatano [Japon]PINK1 autophosphorylation facilitates Parkin recruitment to mitochondria: new insight in the mechanisms of quality control for mitochondria in young-onset Parkinson's disease.
000F37 Maya Ando [Japon] ; Manabu Funayama [Japon] ; YUANZHE LI [Japon] ; Kenichi Kashihara [Japon] ; Yoshitake Murakami [Japon] ; Nobutaka Ishizu [Japon] ; Chizuko Toyoda [Japon] ; Katsuhiko Noguchi [Japon] ; Takashi Hashimoto [Japon] ; Naoki Nakano [Japon] ; Ryogen Sasaki [Japon] ; Yasumasa Kokubo [Japon] ; Shigeki Kuzuhara [Japon] ; Kotaro Ogaki [Japon] ; Chikara Yamashita [Japon] ; Hiroyo Yoshino [Japon] ; Taku Hatano [Japon] ; Hiroyuki Tomiyama [Japon] ; Nobutaka Hattori [Japon]VPS35 Mutation in Japanese Patients with Typical Parkinson's Disease
001267 Taku Hatano [Japon]A novel protein degradation system in young-onset Parkinson's disease: mitophagy is a therapeutic target as a quality control for damaged mitochondria.
001839 Taku Hatano [Japon]A novel protein degradation system in young‐onset Parkinson's disease: Mitophagy is a therapeutic target as a quality control for damaged mitochondria
002303 Yasuyuki Okuma [Japon] ; Satoshi Kamei [Japon] ; Akihiko Morita [Japon] ; Fumihito Yoshii [Japon] ; Toshimasa Yamamoto [Japon] ; Shiori Hashimoto [Japon] ; Hiroya Utsumi [Japon] ; Taku Hatano [Japon] ; Nobutaka Hattori [Japon] ; Miyuki Matsumura [Japon] ; Kazushi Takahashi [Japon] ; Shigeru Nogawa [Japon] ; Yuka Watanabe [Japon] ; Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Koichi Hirata [Japon]Fatigue in Japanese patients with Parkinson's disease: A study using Parkinson fatigue scale
002584 Kazuo Yamashiro [Japon] ; Miki Komine-Kobayashi [Japon] ; Taku Hatano [Japon] ; Takao Urabe [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Yoshitaka Iwama [Japon] ; Hiroyuki Daida [Japon] ; Michi Sakai [Japon] ; Takeo Nakayama [Japon] ; Yoshikuni Mizuno [Japon]The frequency of cardiac valvular regurgitation in Parkinson's disease
003242 Kenichi Sato [Japon] ; Taku Hatano [Japon] ; Kazuo Yamashiro [Japon] ; Maki Kagohashi [Japon] ; Kenya Nishioka [Japon] ; Nana Izawa [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Hideo Mori [Japon] ; Yoshikuni Mizuno [Japon]Prognosis of Parkinson's disease: Time to stage III, IV, V, and to motor fluctuations

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024